Cargando…

Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways

BACKGROUND/AIMS: Fibroblast growth factor (FGF) 21 is associated with hepatic inflammation and fibrosis. However, little is known regarding the effects of inflammation and fibrosis on the β-Klotho and FGF21 pathway in the liver. METHODS: Enrolled patients had biopsy-confirmed viral or alcoholic hepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyong Joo, Jang, Yoon Ok, Cha, Seung-Kuy, Kim, Moon Young, Park, Kyu-Sang, Eom, Young Woo, Baik, Soon Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027831/ https://www.ncbi.nlm.nih.gov/pubmed/29699061 http://dx.doi.org/10.5009/gnl17443

Ejemplares similares

Biological Role of Anti-aging Protein Klotho
por: Kim, Ji-Hee, et al.
Publicado: (2015)

Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions
por: Min, Xiaoshan, et al.
Publicado: (2018)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study
por: Choi, Jung Ran, et al.
Publicado: (2018)

Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome
por: Kim, Ji-Hee, et al.
Publicado: (2016)

The fibroblast growth factor–Klotho axis at molecular level
por: Sun, Fuqiang, et al.
Publicado: (2023)

Soluble αKlotho downregulates Orai1-mediated store-operated Ca(2+) entry via PI3K-dependent signaling
por: Kim, Ji-Hee, et al.
Publicado: (2021)

Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System
por: Moure, Ricardo, et al.
Publicado: (2018)

Fibroblast growth factor 23—Klotho and hypertension: experimental and clinical mechanisms
por: Freundlich, Michael, et al.
Publicado: (2020)

Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
por: Xie, Jian, et al.
Publicado: (2012)

Soluble α-Klotho as a Novel Biomarker in the Early Stage of Nephropathy in Patients with Type 2 Diabetes
por: Lee, Eun Young, et al.
Publicado: (2014)

Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy
por: Suk Kang, Jeong, et al.
Publicado: (2021)

α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent
por: Erben, Reinhold G.
Publicado: (2018)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters
por: Socha-Banasiak, Anna, et al.
Publicado: (2020)

Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
por: Eom, Young Woo, et al.
Publicado: (2019)

Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes : Involvement of Nuclear Factor-κB and c-Jun NH(2)-Terminal Kinase Pathways
por: Jiao, Ping, et al.
Publicado: (2009)

Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
por: Kawabata, Chiaki, et al.
Publicado: (2019)

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
por: Kang, Seong Hee, et al.
Publicado: (2020)

Fibroblast Growth Factor-4 Enhances Proliferation of Mouse Embryonic Stem Cells via Activation of c-Jun Signaling
por: Kook, Sung-Ho, et al.
Publicado: (2013)

c-Jun N-Terminal Kinase Signaling Inhibitors Under Development
por: Han, Sun-Young
Publicado: (2008)

Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
por: Jia, Min-Qi, et al.
Publicado: (2022)

Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease
por: Ding, Hong-Ying, et al.
Publicado: (2015)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: Navarro-García, José Alberto, et al.
Publicado: (2021)

Interleukin-13 inhibits cytokines synthesis by blocking nuclear factor-κB and c-Jun N-terminal kinase in human mesangial cells()
por: Zhu, Chunhua, et al.
Publicado: (2010)

Role of Fibroblast Growth Factor Receptor 2b in the Cross Talk between Autophagy and Differentiation: Involvement of Jun N-Terminal Protein Kinase Signaling
por: Nanni, Monica, et al.
Publicado: (2018)

Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020)

Klotho: An Emerging Factor With Ergogenic Potential
por: Arroyo, Eliott, et al.
Publicado: (2022)

Low Klotho/Fibroblast Growth Factor 23 Ratio Is an Independent Risk Factor for Renal Progression in Chronic Kidney Disease: Finding From KNOW-CKD
por: Kim, Hyo Jin, et al.
Publicado: (2022)

Correction to: Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
Publicado: (2020)

Role of Klotho in Hyperglycemia: Its Levels and Effects on Fibroblast Growth Factor Receptors, Glycolysis, and Glomerular Filtration
por: Typiak, Marlena, et al.
Publicado: (2021)

Ca(2+)-activated mitochondrial biogenesis and functions improve stem cell fate in Rg3-treated human mesenchymal stem cells
por: Hong, Taeui, et al.
Publicado: (2020)

Investigating the role of c-Jun N-terminal kinases in the proliferation of Werner syndrome fibroblasts using diaminopyridine inhibitors
por: Davis, Terence, et al.
Publicado: (2011)

FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
por: Shim, Kwang Yong, et al.
Publicado: (2018)

Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2015)

Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)

Inhibition of c-Jun NH(2)-terminal kinase or extracellular signal-regulated kinase improves lung injury
por: Lee, Hui Su, et al.
Publicado: (2004)

Changes in Serum Concentrations of Fibroblast Growth Factor 23 and Soluble Klotho in Hemodialysis Patients after Total Parathyroidectomy
por: Liao, Shang-Chih, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bdqq5nlph1bdp34t1jgm8mlk59